Effectiveness of Interventions to Prevent Frailty in Older Adults: A Systematic Review and Meta-Analysis
Abstract
Objective: This systematic review and meta-analysis aimed to evaluate the effectiveness of interventions for preventing or managing frailty in adults aged 65 and over, based on evidence from randomized controlled trials.
Methods: A systematic search was conducted using the modified keywords "frailty," "older," and "intervention" across multiple databases, without publication year restrictions, following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. A total of 16 studies were included. The statistical analyses were performed using Comprehensive Meta-Analysis version 4 software. Heterogeneity was assessed using Cochran's Q test and the I2 statistic. Publication bias was examined using funnel plots and Egger's regression test.
Results: The meta-analysis yielded an overall effect size of -0.799 (Z = -2.524, SE = 0.32, 95% confidence interval [-1.420, 0.179]). Heterogeneity was high (Q = 561.205, p < .001, I2 = 97.32%). In subgroup analyses, combined interventions (Hedges' g = 2.843, SE = 1.651, 95% confidence interval [0.376, 6.062]) showed a larger effect size than other intervention types; however, subgroup analyses were not statistically significant (p = .080).
Conclusions: The effectiveness of exercise interventions to improve physical endurance depends on factors such as duration and frequency. Due to the multifactorial nature of frailty, additional approaches-including nutritional support, integrated care, and metformin treatment-also…
How strong is the evidence?
Evidence Hub reads this as a meta-analysis, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.
Read the paper
Related studies
- Metformin as an adjuvant in breast cancer treatment
- Metformin Lysosomal Targeting: A Novel Aspect to Be Investigated for Metformin Repurposing in Neurodegenerative Diseases?
- Aberrant HSF1 signaling activation underlies metformin amelioration of myocardial infarction in mice
- Metformin induces ZFP36 by mTORC1 inhibition in cervical cancer-derived cell lines
- Protein Interaction Network for Identifying Vascular Response of Metformin (Oral Antidiabetic)
- Preventing Long COVID With Metformin
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.